CRO start­up Vial scores $67M Se­ries B led by Gen­er­al Cat­a­lyst

Vial, a CRO spe­cial­iz­ing in of­fer­ing clin­i­cal tri­al ser­vices to biotech com­pa­nies, raised $67 mil­lion in a new round of fund­ing, bring­ing its to­tal mon­ey …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER